These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies. Costa A; Riedel M; Müller U; Möller HJ; Ettinger U Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331 [TBL] [Abstract][Full Text] [Related]
24. A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children. Genro JP; Zeni C; Polanczyk GV; Roman T; Rohde LA; Hutz MH Am J Med Genet B Neuropsychiatr Genet; 2007 Mar; 144B(2):215-9. PubMed ID: 17044101 [TBL] [Abstract][Full Text] [Related]
25. Impaired temporal resolution of visual attention and dopamine beta hydroxylase genotype in attention-deficit/hyperactivity disorder. Bellgrove MA; Mattingley JB; Hawi Z; Mullins C; Kirley A; Gill M; Robertson IH Biol Psychiatry; 2006 Nov; 60(10):1039-45. PubMed ID: 16876143 [TBL] [Abstract][Full Text] [Related]
26. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Asherson P; Brookes K; Franke B; Chen W; Gill M; Ebstein RP; Buitelaar J; Banaschewski T; Sonuga-Barke E; Eisenberg J; Manor I; Miranda A; Oades RD; Roeyers H; Rothenberger A; Sergeant J; Steinhausen HC; Faraone SV Am J Psychiatry; 2007 Apr; 164(4):674-7. PubMed ID: 17403983 [TBL] [Abstract][Full Text] [Related]
27. Environmental risk factors and attention-deficit/hyperactivity disorder symptoms. Freitag CM; Meyer J; Reif A; Rösler M; Lesch KP; Retz W Arch Gen Psychiatry; 2008 Mar; 65(3):356-7; author reply 357-8. PubMed ID: 18316682 [No Abstract] [Full Text] [Related]
28. Principles of haplotype mapping and potential applications to attention-deficit/hyperactivity disorder. Sklar P Biol Psychiatry; 2005 Jun; 57(11):1357-66. PubMed ID: 15950008 [TBL] [Abstract][Full Text] [Related]
29. The genetics of attention-deficit/hyperactivity disorder. Coghill D; Banaschewski T Expert Rev Neurother; 2009 Oct; 9(10):1547-65. PubMed ID: 19831843 [TBL] [Abstract][Full Text] [Related]
30. Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. Todd RD; Huang H; Smalley SL; Nelson SF; Willcutt EG; Pennington BF; Smith SD; Faraone SV; Neuman RJ J Child Psychol Psychiatry; 2005 Oct; 46(10):1067-73. PubMed ID: 16178930 [TBL] [Abstract][Full Text] [Related]
31. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD. van der Meulen EM; Bakker SC; Pauls DL; Oteman N; Kruitwagen CL; Pearson PL; Sinke RJ; Buitelaar JK J Child Psychol Psychiatry; 2005 Oct; 46(10):1074-80. PubMed ID: 16178931 [TBL] [Abstract][Full Text] [Related]
32. Association between the DAT1 gene and spatial working memory in attention deficit hyperactivity disorder. Shang CY; Gau SS Int J Neuropsychopharmacol; 2014 Jan; 17(1):9-21. PubMed ID: 24008096 [TBL] [Abstract][Full Text] [Related]
33. Family-based association analysis of functional VNTR polymorphisms in the dopamine transporter gene in migraine with and without aura. Karwautz A; Campos de Sousa S; Konrad A; Zesch HE; Wagner G; Zormann A; Wanner C; Breen G; Ray M; Kienbacher C; Natriashvili S; Collier DA; Wöber C; Wöber-Bingöl C J Neural Transm (Vienna); 2008; 115(1):91-5. PubMed ID: 17690944 [TBL] [Abstract][Full Text] [Related]
35. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder. Staller JA; Faraone SV Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490 [TBL] [Abstract][Full Text] [Related]
36. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Brookes KJ; Mill J; Guindalini C; Curran S; Xu X; Knight J; Chen CK; Huang YS; Sethna V; Taylor E; Chen W; Breen G; Asherson P Arch Gen Psychiatry; 2006 Jan; 63(1):74-81. PubMed ID: 16389200 [TBL] [Abstract][Full Text] [Related]
37. Molecular imaging of the dopamine transporter. Varrone A; Halldin C J Nucl Med; 2010 Sep; 51(9):1331-4. PubMed ID: 20720060 [TBL] [Abstract][Full Text] [Related]
39. Association between a SLC6A3 intron 8 VNTR functional polymorphism and ADHD in a Brazilian sample of adult patients. Silva MA; Cordeiro Q; Louzã M; Vallada H Braz J Psychiatry; 2009 Dec; 31(4):390-95. PubMed ID: 20098830 [No Abstract] [Full Text] [Related]
40. [Distribution of alleles of the VNTR polymorphism in the 3'-untranslated region of the DAT1 gene (SLC6A3) in São Paulo/Brazil and its importance to genetic studies of neuropsychiatric disorders in ethically admixed populations]. Silva MA; Cordeiro Q; Miracca EC; Guindalini C; Vallada H Rev Med Chil; 2005 Nov; 133(11):1392-3. PubMed ID: 16446865 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]